Your patients may have complicated needs. They not only turn to you for the guidance and understanding to face challenges or make difficult decisions, but they also depend on you for accurate results.
Broad portfolio of clinically relevant, right-sized solutions for patients
As patients consider starting a family, they may want to have a better understanding of their genetic makeup, and whether they are at increased risk of passing along a genetic variant to their children. Genetic carrier screening is a crucial tool to help couples have a better understanding of risk and guide their family planning decisions.
)
Our hereditary cancer solutions close the gap between the unknown and the path forward. A complete portfolio of hereditary cancer tests, services, and expert analysis help you understand patient risk, and is the first step in our approach to patient care.
Spinal muscular atrophy (SMA) is one of the most common recessive genetic conditions, yet it can be challenging to interpret genetic carrier screen results.
Cardiogenetic testing: when CVD risk is hereditary
In many patients, the risk of cardiovascular disease (CVD) may be attributed to genetic polymorphisms and mutations. Quest Diagnostics offers cardiogenetic testing to aid in early diagnosis and earlier treatment for affected patients, as well as family members.
Genetic Insights is a consumer-initiated health screening test that comes with clinical oversight. It identifies DNA variants linked to inherited conditions that put people at higher risk for health conditions like breast cancer, colon cancer, high cholesterol, iron overload, and heart problems. If someone is shown to be at increased risk, there are actions they can take to stay healthy.
The Quest AdvancedTM Oncology portfolio of hereditary cancer tests helps you understand your patient’s risk of cancer and our expert analysis guides your comprehensive approach to patient care.
Read more about our hereditary oncology offerings, professional resources, and patient resources.
Quest Diagnostics offers a wide variety of tests to help diagnose genetic syndromes, from biochemical conditions including inborn errors of metabolism, chromosomal conditions, and rare genetic diseases.
Exome with Copy Number Variant (CNV) evaluation
Chromosomal microarray analysis (CMA)
Inborn Errors of Metabolism (IEM)
Quest Diagnostics offers quality reproductive testing options, from carrier screening, non-invasive prenatal testing to products of conception testing.
Quest Diagnostic's solid tumor test options help clinicians understand cancer-causing variants in advanced tumors to try and aid in the diagnosis, prognosis, and treatment selection specific to that individual patient’s cancer.
Our genomic specialists are here to guide you through the complexities of genetic testing.
Call 1.866.GENE.INFO (1.866.436.3463).
You can get answers, assistance, and advice from board-certified genetic counselors, medical geneticists, and medical directors. Call 1.866.GENE.INFO (1.866.436.3463).
All tests
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services.
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
